ALKEM LABORATORIES
Back to Income Statement
|
ALKEM LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹1,796 Cr | ₹984 Cr | ₹1,646 Cr | ₹1,585 Cr | ₹1,127 Cr |
What is the latest Consolidated Net Profit of ALKEM LABORATORIES ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹1,796 Cr |
Mar2023 | ₹984 Cr |
Mar2022 | ₹1,646 Cr |
Mar2021 | ₹1,585 Cr |
Mar2020 | ₹1,127 Cr |
How is Consolidated Net Profit of ALKEM LABORATORIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹1,796 Cr | 82.47 | |
Mar2023 | ₹984 Cr | -40.19 | |
Mar2022 | ₹1,646 Cr | 3.82 | |
Mar2021 | ₹1,585 Cr | 40.63 | |
Mar2020 | ₹1,127 Cr | - |
Compare Consolidated Net Profit of peers of ALKEM LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALKEM LABORATORIES | ₹59,780.3 Cr | 1.3% | 4.6% | -5.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,872.0 Cr | -2.1% | 1.7% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,609.0 Cr | -1.5% | 1.5% | 46.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,277.0 Cr | 2.5% | 11.2% | 15.3% | Stock Analytics | |
CIPLA | ₹119,184.0 Cr | -1% | -1.7% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,116.0 Cr | -0.1% | -5% | -5.6% | Stock Analytics |
ALKEM LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALKEM LABORATORIES | 1.3% |
4.6% |
-5.1% |
SENSEX | -0.1% |
1% |
1.8% |
You may also like the below Video Courses